SCHEMBL97294

SCHEMBL97294

CNCCCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3211132 0.92
SCHEMBL12849125 0.90 PAOX (0.42)
SCHEMBL26003719 0.90 TSHR (0.40)
SCHEMBL3208475 0.89
SCHEMBL21574011 0.89 EPHX1 (0.48)
SCHEMBL21568867 0.89 EPHX1 (0.48)
SCHEMBL3345518 0.89 EPHX1 (0.48)
SCHEMBL100110 0.81
Hydrochloric Acid SCHEMBL11151896 0.79
SCHEMBL1707503 0.75 TSHR (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2661436-B1 NOVEL SULFAMIDE PIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA AS (DK) 2016-04-13 EP claimed
US-9233964-B2 Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use therof LEO PHARMA A/S (DK) 2016-01-12 US claimed
US-20130345194-A1 SUBSTITUTED CYCLOPENTYL-AZINES AS CASR-ACTIVE COMPOUNDS LEO PHARMA A/S (DK) 2013-12-26 US claimed
EP-2661436-A1 NOVEL SULFAMIDE PIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF Leo Pharma A/S (DK) 2013-11-13 EP claimed
WO-2012093169-A1 NOVEL SULFAMIDE PIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA A/S (DK) 2012-07-12 WO claimed
US-20240352193-A1 POLYAMIC ACID AQUEOUS SOLUTION COMPOSITION KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2024-10-24 US disclosed
WO-2024081311-A1 CBL-B MODULATORS AND USES THEREOF NIMBUS CLIO, INC. (US) 2024-04-18 WO disclosed
EP-4320132-A1 OXAZEPINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCER Genentech, Inc. (US) 2024-02-14 EP disclosed
WO-2023189803-A1 RESIST UNDERLAYER FILM FORMING COMPOSITION 日産化学株式会社 2023-10-05 WO disclosed
WO-2023189799-A1 SELF CROSS-LINKABLE POLYMER AND RESIST UNDERLAYER FILM-FORMING COMPOSITION 日産化学株式会社 2023-10-05 WO disclosed
WO-2023018636-A1 COMPOUNDS THAT INHIBIT PI3K ISOFORM ALPHA AND METHODS FOR TREATING CANCER SCORPION THERAPEUTICS, INC. (US) 2023-02-16 WO disclosed
US-20230041761-A1 SMALL MOLECULE MODULATORS OF SIGMA-1 AND SIGMA-2 RECEPTORS AND USES THEREOF NORTHWESTERN UNIVERSITY 2023-02-09 US disclosed
US-20060183790-A1 Azolylacylguanidines as beta-secretase inhibitors WYETH (US) 2006-08-17 US disclosed
CN-1053472-C Oligonucleotides derived from the SOD family HOFFMANN LA ROCHE (CH) 2000-06-14 CN disclosed
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed
CN-1106405-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating THOMAE GMBH DR K (DE) 1995-08-09 CN disclosed
EP-0580744-A4 BIS(REISSERT COMPOUNDS) FROM REACTION OF MONOALDEHYDE, MONOAMINE AND DIACID HALIDE VIRGINIA TECH INTELL PROP (US) 1994-06-22 EP disclosed
EP-0580744-A1 BIS(REISSERT COMPOUNDS) FROM REACTION OF MONOALDEHYDE, MONOAMINE AND DIACID HALIDE VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1994-02-02 EP disclosed
WO-1992018466-A1 BIS(REISSERT COMPOUNDS) FROM REACTION OF MONOALDEHYDE, MONOAMINE AND DIACID HALIDE VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1992-10-29 WO disclosed
WO-1992018555-A1 POLYAMIDE CONTAINING REISSERT UNIT(S) VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1992-10-29 WO disclosed